Young Seok Byun

Title: Young Seok Byun: Innovator in Pharmaceutical Chemistry

Introduction

Young Seok Byun is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating central nervous system disorders. His innovative work has the potential to impact the medical community positively.

Latest Patents

Young Seok Byun holds a patent for a novel compound, {4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenoxy}phosphate, or a pharmaceutically acceptable salt thereof. This invention includes a production method and a pharmaceutical composition designed for preventing and treating central nervous system disorders. The compound exhibits biological and pharmacological activity comparable to venlafaxine, a known treatment in the field, while demonstrating low toxicity and superior water solubility compared to prior-art venlafaxine derivatives.

Career Highlights

Young Seok Byun is currently associated with Je Il Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and improving therapeutic options for patients suffering from central nervous system disorders.

Collaborations

Young Seok Byun collaborates with esteemed colleagues, including Seok Won Kang and Jong Soo Chun. Their combined expertise fosters a productive research environment that enhances the development of new pharmaceutical solutions.

Conclusion

Young Seok Byun's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the field. His work promises to provide new avenues for treating central nervous system disorders, showcasing the importance of innovation in healthcare.